Just Because the Board Didn T Say It Doesn T Mean That the Board Didn T Think It
In Novartis AG v. Torrent Pharmaceuticals Limited, [2016-1352] (April 12, 2017), the Federal Circuit affirmed the PTAB’s determination that the challenged claims of U.S. Patent No. 8,324,283, and Novartis’ proposed substitute claims, were…
April 18, 2017PTAB3 min read
